360 View Of Healthcare: Balancing Physician Training And Biotech Development

One of In Vivo’s 2023 Rising Leaders, Pheast Therapeutics’ chief development officer Amira Barkal, is also busy becoming a qualified physician. She is in the unusual position of leading an early-stage drug development program and being hands-on helping patients at the same time.

cancer cell
Visual of cancer cell and antibody treatment • Source: Shutterstock

Rising Leaders Home

Pheast Therapeutics was founded in 2020 as a spinout from Stanford University based on Amira Barkal’s research around boosting macrophage...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rising Leaders

More from Leadership